Please login to the form below

Not currently logged in
Email:
Password:

GS-5806

This page shows the latest GS-5806 news and features for those working in and with pharma, biotech and healthcare.

Gilead's RSV drug clears mid-stage trial

Gilead's RSV drug clears mid-stage trial

Gilead's RSV drug clears mid-stage trial. Late-stage data demonstrates GS-5806 is effective in treating the infection. ... The company presented the results of a study of GS-5806, an orally-active RSV fusion inhibitor, showing that it was able to limit

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics